Bladder Cancer Industry, April 2015 Market Reports from Top Publishers

You might be interested in: Diagnostics, Oncology, Drug, Biomarker, Clinical Trial.


 
1-10 of 23 reports for Bladder Cancer

Purchase Reports From Reputable Market Research Publishers

 Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2015

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • April 2015
  • by Delve Insight

SUMMARY DelveInsight’s, “ Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this ...

The 2016-2021 World Outlook for Bladder Cancer Therapeutics

The 2016-2021 World Outlook for Bladder Cancer Therapeutics

  • $ 995
  • Industry report
  • April 2015
  • by ICON Group

This econometric study covers the world outlook for bladder cancer therapeutics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

Bladder Cancer-API Insights, 2015

Bladder Cancer-API Insights, 2015

  • $ 1 250
  • Industry report
  • April 2015
  • by Delve Insight

Summary DelveInsight’s, Bladder Cancer-API Insights, 2015,report provides Bladder Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives ...

 Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2015

Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • April 2015
  • by Delve Insight

SUMMARY DelveInsight’s, “ Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this Non Muscle Invasive Bladde ...

Bladder Cancer Partnering 2010-2015

Bladder Cancer Partnering 2010-2015

  • $ 795
  • Industry report
  • March 2015
  • by Currentpartnering

The Bladder Cancer Partnering 2010-2015 report provides understanding and access to the bladder cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in ...

Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

Bladder Cancer Drug Pathway Analyzer 2015

Bladder Cancer Drug Pathway Analyzer 2015

  • $ 1 499
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 110 targeted molecular therapies known to affect more than 216 specific intracellular signaling pathways ...

Bladder Cancer Drug Pipeline Update 2015

Bladder Cancer Drug Pipeline Update 2015

  • $ 1 499
  • Industry report
  • January 2015
  • by Bioseeker

According to the American Cancer Society, bladder cancer is the 6th most common cancer in the U.S. Bladder cancer occurs among both men and women. When found and treated early, the 5 year survival rate ...

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2014, Global Markets Direct

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2014, Global Markets Direct

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladde ...

 Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2014

Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“ Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of ...

About 1 600 reports for Bladder Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • January 2014
    42 pages
  • Cancer  

    Oncology  

    Bladder Cancer  

  • United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.